Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant
Clinical trial NCT04368988 · COMPLETED
Trial details
- NCT number
- NCT04368988
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-25
- Primary completion
- 2022-06-01
- Enrollment
- 1419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.